Is an interlaminar lumbar/sacral epidural steroid injection (LESI) medically necessary for a patient with low back pain and radiating pain, despite no documented 50% or greater relief in pain, increase in function, or reduction in pain medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Necessity Determination for Repeat Interlaminar Lumbar Epidural Steroid Injection

This Procedure is NOT Medically Necessary

The requested repeat interlaminar lumbar/sacral epidural steroid injection (CPT 62323) is NOT medically necessary for this patient because she has failed to demonstrate the required objective evidence of benefit from her previous three injections, specifically lacking documentation of at least 50% pain relief for at least 2 weeks, functional improvement, or reduction in pain medication use. 1

Critical Missing Documentation

The patient has received three prior interlaminar epidural steroid injections (most recently in DATE) but the medical record contains no objective documentation of:

  • 50% or greater pain relief lasting at least 2 weeks following any prior injection 1, 2
  • Measurable functional improvement (e.g., return to work, increased walking distance, resumption of daily activities) 1
  • Reduction in pain medication use or decreased need for other medical services 1

The patient's subjective statement that "her last LESI in [DATE] has provided significant relief" is insufficient without objective documentation of the degree and duration of relief. 1

Evidence-Based Criteria for Repeat Injections

Guideline Requirements for Additional Injections

The American Society of Anesthesiologists explicitly requires that repeat therapeutic epidural steroid injections should only be performed if the initial injection resulted in at least 50% pain relief for at least 2 weeks. 1 This is not documented in this case.

The comprehensive pain management criteria state that additional interlaminar epidural injections require the patient achieved at least two of the following for at least two weeks: 1

  • 50% or greater pain relief (NOT MET)
  • Increased level of function/physical activity (NOT MET)
  • Reduction in pain medication use (NOT MET)

This patient has met zero of these three criteria based on available documentation. 1

Diagnostic Concerns

Lack of True Radiculopathy Documentation

The American College of Physicians defines radicular pain specifically as pain and/or numbness that radiates below the knee, which is the specific requirement for epidural steroid injection authorization. 1, 3 This patient's documentation states "radiation of pain, bilateral, buttock(s), hip(s)" but does not clearly document radiation below the knee. 1

The American Academy of Neurology explicitly recommends against epidural steroid injections for non-radicular low back pain, as evidence for their use is limited. 1, 3 Pain radiating only to the buttocks and hips does not meet criteria for true radiculopathy. 1

Alternative Pain Generators Not Addressed

The bilateral buttock and hip pain pattern raises concern for:

  • Sacroiliac joint pathology - which would not respond to lumbar epidural injections 1
  • Facet-mediated pain - which requires different diagnostic and therapeutic approach 4, 1
  • Hip joint pathology - particularly given the recent plantar fasciitis and mobility issues 1

Repeating an ineffective intervention without evaluating alternative pain sources exposes the patient to unnecessary procedural risks. 1, 2

Risk-Benefit Analysis

Documented Complications

Interlaminar epidural steroid injections carry significant risks including: 1, 2

  • Dural puncture
  • Insertion-site infections
  • Cauda equina syndrome
  • Sensorimotor deficits
  • Discitis
  • Epidural granuloma
  • Retinal complications
  • Rare catastrophic complications including paralysis and death

Exposing this patient to these risks without demonstrated benefit from prior injections is not justified. 1

Evidence Quality for Repeat Injections

While epidural steroid injections show strong evidence for short-term relief (2 weeks to 3 months) in patients with true radiculopathy 5, 6, the evidence specifically for repeat injections in non-responders is lacking. 1

One high-quality randomized trial showed that only 30% of patients with moderate stenosis and 17.9% of patients with severe stenosis achieved ≥50% pain relief at 3 months, demonstrating limited long-term effectiveness even in appropriate candidates. 7

What Should Happen Instead

Required Before Repeat Injection

  1. Obtain objective documentation of response to prior injections using validated pain scales (VAS/NRS) and functional measures at specific time intervals (2 weeks, 1 month, 3 months) 1, 2

  2. Evaluate alternative pain generators: 1

    • Sacroiliac joint provocation testing (if 3 of 6 tests positive, consider diagnostic SI joint injection)
    • Facet joint evaluation with diagnostic blocks using double-injection technique
    • Hip joint evaluation given bilateral hip pain complaints
  3. Optimize comprehensive pain management program including: 1, 2

    • Structured physical therapy with documented compliance and objective functional goals
    • Patient education regarding pain mechanisms and self-management
    • Psychosocial support if indicated
    • Optimization of oral medications
  4. Review imaging correlation: Confirm that MRI findings (obtained within 24 months) demonstrate nerve root compression that correlates anatomically with the patient's symptom distribution 1, 2

Clinical Pathway Forward

Do not repeat injections based solely on patient request without objective evidence of prior benefit. 1 The patient's statement that "when she does not stay on top of doing them about every 3 months her pain worsens" suggests she is using these injections as maintenance therapy without documented efficacy, which is explicitly excluded from coverage criteria. 1

If the patient develops clear radiculopathy with radiation below the knee and demonstrates objective benefit from a properly documented trial injection (≥50% pain relief for ≥2 weeks), then repeat injection may be reconsidered. 1, 2 However, the current clinical presentation and lack of documented response does not support medical necessity. 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.